Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 9.50
-0.26 (-2.66%)
At close: Apr 9, 2026
Sinotherapeutics Market Cap
Sinotherapeutics has a market cap or net worth of 4.27 billion as of April 9, 2026. Its market cap has decreased by -8.39% in one year.
Market Cap
4.27B
Enterprise Value
3.50B
Revenue
446.50M
Ranking
n/a
PE Ratio
86.36
Stock Price
9.50
Market Cap Chart
Since August 25, 2022, Sinotherapeutics's market cap has decreased from 6.17B to 4.27B, a decrease of -30.82%. That is a compound annual growth rate of -9.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 4.27B | -2.06% |
| Dec 31, 2025 | 4.36B | -3.58% |
| Dec 31, 2024 | 4.52B | -9.26% |
| Dec 29, 2023 | 4.98B | -34.45% |
| Dec 30, 2022 | 7.59B | 23.16% |
| Aug 25, 2022 | 6.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yabao Pharmaceutical Group | 4.50B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.48B |
| LanZhou Foci Pharmaceutical | 4.41B |
| Shanghai Xiao Fang Pharmaceutical | 4.39B |
| Jinhe Biotechnology CO., LTD. | 4.34B |
| PKU HealthCare Corp.,Ltd. | 4.25B |
| Honz Pharmaceutical | 4.17B |
| Shanghai MicuRx Pharmaceutical | 4.13B |